Whatever Ethics We Are Legislating, Money is Overriding

Back in 2003 when I worked in pharma, this would have been major mind-boggling news (when Pfizer paid over $400M in fines). Now, almost 10 years later, pharmacos “set aside money” for penalty and this sort of news is no longer news. Whatever ethics we are legislating, it is obviously not working against financial incentives that drive this behavior.

http://www.nytimes.com/2012/12/19/business/amgen-agrees-to-pay-762-million-in-drug-case.html

Leave a Reply

Your email address will not be published. Required fields are marked *